The infamous Covid-19 vaccine ‘alternative’ makes headlines again, though now we might finally find out the efficacy rates of it.
The findings of a study done on the discourse-stirring medicine are expected to be presented to the Health Ministry stakeholders within the next month.
The clinical trial, titled “Ivermectin Treatment Efficacy in Covid-19 High-Risk Patients,” (I-Tech for short), will consist of 500 patients which will be recruited by the end of September, said Health Minister Khairy Jamaluddin.
“After that, the findings of the study are expected to be presented to the Health Ministry’s stakeholders in October,” he said.
Oscar Ling Chai Yew of Harapan-Sibu had previously asked the minister himself to reveal information and particulars on the preliminary findings of I-Tech.
Khairy had issued a parliamentary reply to Oscar yesterday, providing more details about the clinical trial.